JAMP-Guanfacine XR 4 mg: Foreign matter
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Product quality - Product safety
What you should do
- Check your or your child's pill bottle to ensure that the green JAMP Guanfacine XR 4mg tablets do not have any brown or amber-coloured stains. If stains are identified, or if you are unsure, return it to your pharmacy for a replacement.
- Talk to a health care professional if you have questions or have health concerns.
- Contact JAMP Pharma Corporation by calling 450-449-4326 (option 3) or 1-866-399-9091 (option 3), or by email at custjamp@jamppharma.com if you have questions about this recall.
- Report any health product-related side effects or complaints to Health Canada.
- Additional information for health professionals:Health care professionals, such as pharmacists, should check bottles of Guanfacine XR 4 mg tablets before dispensing and report any unusual tablets or other issue to the company and to Health Canada.
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
2026-11-06
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.